EGFR and non-small cell lung carcinoma: In this study, in which we included 785 surgically resected NSCLC patients and identified 36 patients among them who developed postoperative BM, we sought to explore the predictive factors for overall and post-recurrence survival, with a particular focus on EGFR mutation statuses and treatment with different TKIs.